Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes
The DOI matches its Crossref record.
Abstract
BACKGROUND: The eye possesses unique anatomical features that make it a valuable target for gene therapy applications. OBJECTIVE: The aim of the current study was to compare transduction efficiency, safety and biodistribution of four viral vectors following intravitreal injection. METHOD: Adenovirus (AdV), Adeno-Associated Virus (AAV), Baculovirus (BV) and Lentivirus (LV) vectors encoding Green Fluorescent Protein (GFP) were injected bilaterally intravitreally into adult C57BL/6OlaHsd mice. Control mice received saline. Eyes and other organs were studied at multiple time points from 3 days to 6 months. Immunohistochemical stainings with retinal cell markers were performed to verify GFP-positive cells. Biodistribution in retina and various non-target tissues was studied using a qPCR method. Inflammatory responses and toxicity were investigated from cryostat eye sections and serum samples. RESULTS: AAV-injected eyes showed GFP expression both in inner and outer retinal cells from 7 days up to 6 months. LV eyes showed long lasting transgene expression mostly in retinal pigment epithelium whereas AdV transiently transduced mainly cells in the anterior chamber. In BV-injected eyes, GFP positivity was very low. qPCR results showed that AdV, AAV and LV spread into the optic nerve, but were below the detection limit in other organs. The strongest immune responses were evoked by intravitreal injections of AdV and BV. The highest concentration of anti-GFP IgG was detected in the AdV-treated group, whereas the AAV group showed the lowest concentration. Neither blood chemistry screen nor the number of apoptotic cells showed any differences between the viral vector and saline injected groups. CONCLUSION: Our findings show that intravitreal gene delivery is safe and feasible with AAV, AdV and lentivirus vectors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lentiviruses are possibly more immunogenic than AAVs.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [27]
In the citing paper
“In previous studies, AAV2 has been shown to transduce the GCL, inner parts of the retina, and the optic nerve after IVT injection in mice (Hellström et al., 2009; Kalesnykas et al., 2017) and the RPE and photoreceptors after subretinal injection (Pang et al., 2008).”
From AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery (2023) · cites this paper as Kalesnykas et al., 2017
In the citing paper
“In a study comparing the transduction efficiency and safety of different viral vectors, GFP packaged in AAV, LV, Adenovirus (Ad) and Baculovirus (BV) was delivered intravitreally to C57BL/6OlaHsd mice.By GFP immunolabelling on retinal sections, the study concluded that LV could have a long-lasting transgene-GFP expression in the RPE, which was stronger than the expression of Ad but weaker than AAV”
From Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy (2022) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
Early and late stage gene therapy interventions for inherited retinal degenerations
Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190
Gene therapy for inherited retinal diseases: Progress and possibilities
Hu, M. L., Edwards, T. L., O’Hare, F., Hickey, D. G., Wang, J.-H., Liu, Z., & Ayton, L. N. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1880863 · Cited by 118
Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
“Such viral composition is particularly useful for diseases with large causative genes such as Stargardt disease and Usher syndrome.22,25,26 Lentiviruses are possibly more immunogenic than AAVs.27 Binley et al found that 5 out of 6 non-human primates that were injected with EIAV in their subretinal space developed a pe…”
BackgroundAAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 79
Baculovirus for gene delivery to mammalian cells: Past, present and future
Mansouri, M., & Berger, P. (2018) · Plasmid · doi:10.1016/j.plasmid.2018.05.002 · Cited by 61
Metadata
- Authors
- Kalesnykas, G., Kokki, E., Alasaarela, L., Lesch, H. P., Tuulos, T., Kinnunen, K., Uusitalo, H., Airenne, K., & Yla-Herttuala, S.
- Affiliations
- Experimentica Ltd., Microkatu 1, 70211 Kuopio, Finland
- University of Eastern Finland (FI)
- Kuopio University Hospital (FI)
- Tampere University (FI)
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O.Box 1627, 70211 Kuopio, Finland
- Venue
- Current Gene Therapy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2017-12-12
- Volume
- 17
- Issue
- 3
- Pages
- 235-247
- ISSN
- 1566-5232 (ISSN-L)
- OpenAlex
- W2761366732
- Cited by
- 43
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 5
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- ocular gene therapy, adeno-associated virus vectors, adenoviral vector, baculovirus vectors, lentiviral vectors, intravitreal injection, retinal transduction, retinal pigment epithelium, immune response, vector safety, GFP expression, retinal inflammation
- MeSH terms
- Dependovirus, Adenoviridae, Animals, Cells, Cultured, Genetic Vectors, Mice, Inbred C57BL, Neuroglia, Tissue Distribution, Genetic Therapy, Lentivirus, Baculoviridae, Green Fluorescent Proteins, Mice, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes. https://app.cochat.ai/papers/10.2174/1566523217666171003170348
- The paper
- Kalesnykas, G., Kokki, E., Alasaarela, L., Lesch, H. P., Tuulos, T., Kinnunen, K., Uusitalo, H., Airenne, K., & Yla-Herttuala, S. (2017). Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes. Current Gene Therapy. https://doi.org/10.2174/1566523217666171003170348
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.